Treatment of rheumatoid arthritis with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in 2022 – real-world data from the Romanian Registry of Rheumatic Diseases

Objective. The study aimed at characterizing the evolution of RA treatment with b/tsDMARDs in Romania, since the end of the SARS-CoV-2 pandemic and the national approval of JAKi. Methods. Data on RA patients was obtained from the Romanian Registry of Rheumatic Diseases database between January 1st,...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Elena Rezus, Claudiu C. Popescu, Corina Mogosan, Claudiu Avram, Razvan-Constantin Ionitescu, Ioana Felea, Ileana-Cosmina Filipescu, Catalin Codreanu
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Amaltea Medical Publishing House 2023-09-01
סדרה:	Romanian Journal of Rheumatology
נושאים:	rheumatoid arthritis romanian registry of rheumatic diseases biologic treatment
גישה מקוונת:	https://rjr.com.ro/articles/2023.3/RJR_2023_3_Art-07.pdf
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!